跳至主要内容
临床试验/CTRI/2025/07/091321
CTRI/2025/07/091321尚未招募不适用

Assessment of efficacy of Malayufal Modak in Raktapradar : Randomised Controlled Trial

PMTs Ayurved College, Shevgaon1 个研究点 分布在 1 个国家目标入组 72 人开始时间: 2025年7月28日最近更新:

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
72
试验地点
1
主要终点
Assessment of efficiency of Malayufal modak in Raktapradar

研究概览

简要总结

The prevalence of DUB varies widely but an incidence is about 10% amongst new patient attending out patient. Various studies suggest that 30-50 % of women in the reproductive age group suffer from excessive and irregular uterine bleeding by different causative factors. 28% of the female population consider their menstruation bleeding excessive and will plan their social activities around their periods and 10% wf employed woman need to take time off work because of excessive bleeding.. Over 75000 Hystrectomies  are now carried out every year. According to to modern science most frequent treatment used in Raktapradar is antifibrinolytic agents, hormonal therapy. But is has its limitations and contraindicated in certain conditions. And hence there is need for herbal drugs that can be used for all patients to overcome temporary phenomenon. Here Malayufal has been choosen for study due to its stambhak effect, tikta kashay rasa katu vipak sheet virya laghu and ruksha guna also pittha kaphashamak properties... The chemical composition found in malayufal is taking which act as an haemostatic medicine due to the astringent property.. This drug is easily available easy to take and cost effective..

研究设计

研究类型
Interventional
分配方式
Randomized
盲法
None

入排标准

年龄范围
18.00 Year(s) 至 45.00 Year(s)(—)
性别
Female

入选标准

  • 1 Patient fulfilling diagnostic criteria-patient complaining of previous history of raktapradar for at least two consecutive cycle 2 Age group between 18 to 45 3 The duration of bleeding must be more than 7 days and quantity must be more than 3 pads per day per cycle.

排除标准

  • 1 Patient suffering from severe anemia 2 know case of any pelvic pathology like tubo ovarian mass fibroids polyp malignant tumors endometriosis 3 know case of thyroid dysfunction hypertension TB DM 4 Patients with previously diagnosed bleeding disorders like hemophilia Von Willebrand disease 5.patients with IUCD OC pills.

结局指标

主要结局

Assessment of efficiency of Malayufal modak in Raktapradar

时间窗: 5 days treatment with fallow up on 0,15,30,45,60,75,90th day

次要结局

  • 1 To review the disease of Raktapradar in details according to Ayurveda and Modern(2 To study efficacy of Dhataki pushpa churna in Raktapradar)

研究者

发起方
PMTs Ayurved College, Shevgaon
申办方类型
Private medical college
责任方
Principal Investigator
主要研究者

Shital Mahadev Gawali

PMTs Ayurved College, shevgaon.

研究点 (1)

Loading locations...

相似试验